Prior exposure to cold viruses boosts antibody response against SARS-CoV-2

Prior exposure to cold viruses boosts antibody response against SARS-CoV-2

[ad_1] Prior exposure to coronaviruses that cause ordinary colds can boost the immune system’s ability to attack a vulnerable site on the COVID-19-causing coronavirus SARS-CoV-2, according to a study led by investigators at Weill Cornell Medicine. The finding suggests a new vaccination strategy that might provide broader and more durable protection against SARS-CoV-2 strains compared…

Read More
Non-standard baby formula linked to faster infant growth

Non-standard baby formula linked to faster infant growth

[ad_1] Researchers from the University of Iowa found that babies fed lactose-free or hydrolyzed formulas gained weight faster in their first year, raising new questions about how modern formula compositions may shape lifelong health. Study: Effects of Infant Formula Type on Early Childhood Growth Outcomes: A Retrospective Cohort Study. Image credit: New Africa/Shutterstock.com With childhood…

Read More
Simple tools increase pediatrician compliance with early peanut allergy prevention guidelines

Simple tools increase pediatrician compliance with early peanut allergy prevention guidelines

[ad_1] A few easy-to-implement tools – a training video, electronic health record prompts and handouts for families – greatly increased how often pediatricians recommended early peanut introduction to infants, reports a new clinical study led by Northwestern University and Ann & Robert H. Lurie Children’s Hospital of Chicago. Since 2017, national guidelines have encouraged pediatricians…

Read More
New NIH grant supports development of experimental pediatric HIV vaccine

New NIH grant supports development of experimental pediatric HIV vaccine

[ad_1] A multi-institutional team led by Weill Cornell Medicine investigators has been awarded a five-year, $20.8 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, for advanced preclinical development of a promising experimental HIV vaccine. A successful vaccine to prevent new HIV infections would be a…

Read More
Disrupting protein quality control slows tumor growth in pediatric rhabdomyosarcoma

Disrupting protein quality control slows tumor growth in pediatric rhabdomyosarcoma

[ad_1] A new research paper was published in Volume 16 of Oncotarget on August 29, 2025, titled “In vivo manipulation of the protein homeostasis network in rhabdomyosarcoma.” In this study led by first author Kristen Kwong and corresponding author Amit J. Sabnis from the Department of Pediatrics, Division of Oncology, University of California San Francisco, researchers discovered that disrupting…

Read More